Cardio

St. Jude Medical, Inc. has announced the European launch of the Unify Quadra cardiac resynchronization therapy defibrillator

Clearstream Technologies has agreed to be sold to Bard for 85p a share

Abiomed, Inc. has announced the first patient enrolled in MINI-AMI, an FDA prospective, randomized, controlled multi-center study to assess the role of 24-hours of direct unloading of the left ventricle with Impella(R) 2.5 support to reduce infarct size in patients with ST-elevation myocardial infarction without cardiogenic shock.

The European Association of Cardiothoracic Surgeons (EACTS) Annual Meeting will take place in Lisbon, 1-5th October, 2011

Promote Quadra CRT-D offers physicians the ability to address pacing complications without the need to surgically reposition a lead

MiCardia Corporation announced today that it has received the CE-Mark approval for commercial sales of its enCorSQ Mitral Valve Repair System in Europe and select countries worldwide.

Biotronik PREVENT study indicates lower percent of right ventricular pacing (%VP) correlates with less risk of heart failure (HF) hospitalization, mortality and atrial fibrillation (AF)

Investigators reported that cardiac survival of patients, who were implanted with the 21F CoreValve system in 2005 and 2006, was 77.9 percent at two years and 68 percent at four years; in other Medtronic news, company announces completing the acquisition of Peak Surgical Inc. and Salient Surgical Technologies Inc.

Intra-aortic balloon pump counterpulsation prior to PCI in patients with ST segment elevation MI does not reduce infarct size as measured by MRI, according to results from the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction (CRISP AMI) trial.

The results of the first randomised controlled trial comparing percutaneous mitral valve repair against conventional mitral valve surgery suggests the short term advantages of the technique may be outweighed by inferior long term results compared with conventional surgery.

Boston Scientific Corp. said Thursday that a District Court jury in Delaware found that Cordis Corp., the stent-making unit of … continue reading “Jury awards Boston Scientific $19.5M in Cordis patent case”

The first ETHICON Cardiac Symposium was held at the SCTS 2011 Conference on March 21st at the EXCEL Centre, London.

New sealant film reduces air leaks in open lung surgery and now with keyhole surgery instrumentation.

Medtronic, Inc. today announced that it has settled a patent lawsuit it initiated against W.L. Gore & Associates.

Two-Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS® EXPRESS® Stents and Bypass Surgery.

Cardiola AG announced today that it has placed its patented m.pulse® system in 10 hospitals located in Germany and Switzerland, on the heels of the system’s CE-Mark approval.